von Redaktion LCGC | Juli 15, 2013
Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib Bos M, Gardizi M, Schildhaus HU, Heukamp LC, Geist T, Kamminsky B, Zander T, Nogova L, Scheffler M, Dietlein...
von Redaktion LCGC | Mai 15, 2013
Lessons Learned From Lung Cancer Genomics: The Emerging Concept of Individualized Diagnostics and Treatment Buettner R, Wolf J, Thomas RK Journal: Journal of Clinical Oncology, Vol 15, No 15, May 2013, doi:10.1200/jco.2012.45.9867 Veröffentlichung: Mai...
von Redaktion LCGC | Apr. 15, 2013
FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications Schildhaus HU, Nogova L, Wolf J, Buettner R Journal: Translational lung cancer research, Vol 2, No 2, April 2013, doi:10.3978/j.issn.2218-6751.2013.03.03...
von Redaktion LCGC | Apr. 15, 2013
Activated RET and ROS: two new driver mutations in lung adenocarcinoma Bos M, Gardizi M, Schildhaus HU, Buettner R, Wolf J Journal: Translational lung cancer research, Vol 2, No 2, April 2013. doi: 10.3978/j.issn.2218-6751.2013.03.08 Veröffentlichung: April...
von Redaktion LCGC | Apr. 15, 2013
Tumor VEGFR:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer Chatterjee S, Heukamp LC, Siobal M, Schöttle J, Wieczorek C, Peifer M, Frasca D, Koker M, König K, Meder L, Rauh D, Buettner R, Wolf J, Brekken RA, Neumaier B, Christofori G, Thomas...
